查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1716869

海洋生物技术市场按产品类型、来源、技术、应用、最终用户划分－2025-2030 年全球预测

Marine Biotechnology Market by Product Type, Source, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计海洋生物技术市场在 2024 年的价值将达到 82.8 亿美元，2025 年将达到 88.8 亿美元，到 2030 年预计将达到 127.9 亿美元，复合年增长率为 7.51%。

主要市场统计数据
基准年2024年 82.8亿美元
预计2025年 88.8亿美元
预测年份 2030 127.9亿美元
复合年增长率（%） 7.51%

海洋生物技术处于科学创新的前沿，将海洋的奇妙与先进技术的突破相结合，以解决世界上一些最紧迫的挑战。过去几年，行业专家见证了由环境问题、技术进步和研发投资激增等因素共同推动的快速发展。这种转变不仅为药物研发和健康应用开闢了新途径，也为针对环境保护、能源生产和高效食品供应系统的永续工业解决方案开闢了新途径。

该行业的成长与世界对永续实践的重新关注密切相关。相关人员已经认识到海洋生态系统具有提供尚未开发的生物活性化合物和生物材料库的巨大潜力。随着政府和私人投资者投入大量资源探索这些海洋资源，该领域的多学科专家之间的合作正在加强，从微生物学家和化学工程师到资料科学家和政​​策制定者。这种人才的融合产生了强大的协同效应，不断创造有希望的机会和创新产品。

摘要旨在强调影响市场发展的动态变化，强调关键细分考虑因素和区域趋势，并为寻求获得竞争优势的行业领导者提供重要建议。本概述采用综合办法，既是介绍，也是探索海洋生物技术新途径的号召。

改变海洋生物技术市场

近年来，海洋生物技术领域的竞争格局正在发生新的变化。分子生物学、数据分析和水产养殖方法的进步促进了新经营模式和研究范式的出现。目前，先驱研究主要集中于基因组学和非培养技术，从而发现具有在各个工业领域应用潜力的独特海洋化合物。快速的技术进步不仅扩大了生物活性水产品的范围，而且重塑了传统的供应链和生产流程。

推动这一演变的是从传统方法到创新技术方法的转变，其中结合了独立于培养的技术和复杂的分离培养方法。这种适应性将使我们能够更精确地表征海洋生物，从而实现工业规模的生产和对以前无法接近的微生物群落的详细研究。采用新工作流程的灵活性使市场参与者能够最大限度地降低生产成本，同时提高产品的特殊性和功效，从而使海洋生物技术对投资者和开发商越来越有吸引力。

同时，人们对环境永续性的认识不断提高，以及绿色解决方案的经济要求正在重塑战略投资。该领域的转型特点是将科学研究与市场需求的理解进行深思熟虑的结合，将海洋生物技术定位为突破性创新的关键培养箱。随着全球对永续、增进健康的产品的需求激发研究工作和策略伙伴关係，未来的发展预计将进一步突破界限。这些变革性转变的巩固标誌着产业内部正朝着更有效率、创新和永续的流程迈进。

海洋生物技术市场的关键细分洞察

在分析海洋生物技术市场时，详细的细分见解提供了不断变化的趋势和新兴机会的清晰图像。当根据产品类型考察市场时，生物活性化合物和生物材料受到了广泛关注。这种双重关注使公司能够开发广泛的产品，从旨在实现高功效的药物化合物到满足技术工业要求的专用生医材料。同样，基于源的分割揭示了涵盖珊瑚和海绵、海洋藻类、海洋真菌和海洋病毒的广泛研究。每一种天然来源都对生物活性特征有着独特的贡献，提供了广泛应用所必需的独特生化特性。

基于技术的进一步划分强调了与微生物分离和培养同时进行的培养独立技术的重要性。这种双重观点确保调查方法足够强大和灵活，以捕捉和培育海洋生物的复杂性。深入研究基于应用的细分，市场研究涉及水产养殖和渔业、生质燃料、药物发现、环境和人类健康、食品供应以及工业产品和流程等领域。如此广泛的应用凸显了该行业影响现代工业和生活方式许多方面的能力。

此外，根据最终用户的细分，市场参与分为化学、化妆品、能源、食品工业以及医疗和製药领域。这种分层细分方法是了解如何定位和服务不同客户群的关键。结构化细分提供了全面的视图，可协助相关人员调整其产品和策略，从而推动每个特定领域的成长和创新。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 提高人们对海洋生物多样性和保育的认识
      • 消费者对生物来源的天然成分的需求不断增加
      • 製药业对海洋衍生化合物的兴趣日益浓厚
    • 限制因素
      • 研发高成本
    • 机会
      • 增加对海洋基因组学的资助，用于发现新型态酶
      • 对源自海藻的环保生质燃料的需求不断增加
    • 任务
      • 平衡海洋生物技术的永续性和商业性利益
  • 市场区隔分析
    • 产品类型：具有抗菌和抗癌特性的生物活性化合物的生长偏好
    • 应用：海洋生物技术在水产养殖和渔业的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 海洋生物技术市场（依产品类型）

  • 生物活性化合物
  • 生物材料

7. 海洋生物技术市场（依来源）

  • 珊瑚和海绵
  • 海藻
  • 海洋真菌
  • 海洋病毒

8. 海洋生物技术市场（依技术）

  • 独立于文化的技术
  • 微生物分离与培养

第九章海洋生物技术市场（按应用）

  • 水产养殖及渔业
  • 生质燃料
  • 药物研发
  • 环境与人类健康
  • 粮食供应
  • 工业产品和工艺

第 10 章 海洋生物技术市场（依最终使用者）

  • 化学品
  • 化妆品
  • 活力
  • 食品工业
  • 医疗和製药

11.美洲海洋生物技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12.亚太海洋生物技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13.欧洲、中东和非洲海洋生物技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Aker BioMarine ASA
  • BASF SE
  • Benchmark Holdings plc
  • Biolchim Group by JM Huber Corporation
  • BioLume, Inc.
  • BlueBioTech GmbH
  • Cellana Inc.
  • Corbion NV
  • DSM-Firmenich AG
  • Earthrise Nutritionals LLC
  • GeoMarine Biotechnologies（P）LTD
  • GlycoMar Ltd.
  • Marine Biopolymers Ltd.
  • Marinova Pty Ltd
  • Marshall Marine Products
  • Nofima
  • oceanBASIS GmbH
  • Pharma Mar, SA
  • PROLUME, LTD
  • Seppic SA
  • The GELITA Group
  • Veramaris VOF
  • Xanthella Ltd.
  • ZIVO Bioscience, Inc.
Product Code: MRR-02026C4C9A70

The Marine Biotechnology Market was valued at USD 8.28 billion in 2024 and is projected to grow to USD 8.88 billion in 2025, with a CAGR of 7.51%, reaching USD 12.79 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 8.28 billion
Estimated Year [2025] USD 8.88 billion
Forecast Year [2030] USD 12.79 billion
CAGR (%) 7.51%

Marine Biotechnology stands at the frontier of scientific innovation, blending the mysteries of the sea with advanced technological breakthroughs to address some of the world's most pressing challenges. In recent years, industry experts have witnessed a rapid evolution driven by a combination of environmental imperatives, technological advancements, and a surge in investment in research and development. This transformation has opened new pathways not only for drug discovery and health applications but also for sustainable industrial solutions that target environmental conservation, energy production, and efficient food supply systems.

The sector's growth is deeply intertwined with a renewed global focus on sustainable practices. Stakeholders are recognizing the immense potential of the marine ecosystem, which offers an untapped reservoir of bioactive compounds and biomaterials. As governments and private investors channel significant resources into exploring these oceanic resources, the field has experienced increased collaboration between multidisciplinary experts, ranging from microbiologists and chemical engineers to data scientists and policy makers. This confluence of talents is creating powerful synergies that continue to unveil promising opportunities and innovative products.

This summary is designed to provide clarity on the dynamic changes shaping the market's evolution, highlight key segmentation insights and regional trends, and offer imperative recommendations for industry leaders looking to seize competitive advantages. With a comprehensive approach that bridges scientific insight and market analysis, this overview serves as both an introduction and a call to explore novel avenues in marine biotechnology.

Transformative Shifts in the Marine Biotechnology Landscape

Recent years have seen transformative shifts that redefine the competitive landscape in marine biotechnology. A confluence of advancements in molecular biology, data analytics, and cultivation methods has catalyzed the emergence of new business models and research paradigms. Pioneering studies now focus on genome analysis and culture-independent techniques leading to the discovery of unique marine compounds with applications across various industries. Rapid technological progress has not only widened the scope of biologically active marine products, but it has also restructured traditional supply chains and manufacturing processes.

A driving force behind this evolution is the shift from classical methodologies to innovative technical approaches that incorporate both culture-independent techniques and refined isolation and cultivation methods. Such adaptations allow for more precise characterization of marine organisms, enabling industrial-scale production and in-depth exploration of previously inaccessible microbial colonies. The agility in adopting new workflows has allowed market players to minimize production costs while enhancing product specificity and efficacy, making marine biotechnology an increasingly attractive prospect for investors and developers alike.

Simultaneously, heightened awareness of environmental sustainability and the economic imperatives of green solutions have reshaped strategic investments. This sector's transition is marked by a thoughtful integration of scientific research with an understanding of market needs, positioning marine biotechnology as a crucial incubator for breakthrough innovations. Future developments promise to push the envelope even further, as global demands for sustainable and health-enhancing products galvanize research efforts and strategic partnerships. The integration of these transformative shifts underlines a vibrant movement toward more efficient, innovative, and sustainable processes within the industry.

Key Segmentation Insights in Marine Biotechnology Markets

In analyzing the marine biotechnology market, detailed segmentation insights provide a clear picture of evolving trends and emerging opportunities. When examining the market based on product type, significant attention is drawn to bioactive compounds and biomaterials. This dual focus allows companies to develop products that range from pharmaceutical compounds designed for high efficacy to specialized biomaterials that meet technical industrial requirements. Similarly, the segmentation based on source reveals an expansive study that spans corals and sponges, marine algae, marine fungi, and marine viruses. Each of these natural sources contributes uniquely to the bioactive profile and offers distinct biochemical properties essential for a wide array of applications.

Further segmentation based on technology highlights the importance of culture-independent techniques alongside the isolation and cultivation of microorganisms. This dual perspective ensures that research methodologies are robust and versatile enough to capture and nurture the complexity of marine organisms. Delving into application-based segmentation, the market is studied across domains such as aquaculture and fishery, biofuels, drug discovery, environmental health and human health, food supply, and industrial products and processes. Such a varied application landscape underscores the sector's capacity to influence multiple facets of contemporary industry and lifestyle.

Moreover, the segmentation based on end-user categorizes market engagement across the chemical, cosmetics, energy, food industry, and medical and pharmaceutical fields. This layered segmentation approach is critical in understanding how diverse customer bases are targeted and served. The structured breakdown offers a comprehensive view that helps stakeholders tailor products and strategies, thereby fostering growth and innovation across each specific segment.

Based on Product Type, market is studied across Bioactive Compounds and Biomaterials.

Based on Source, market is studied across Corals & Sponges, Marine Algae, Marine Fungi, and Marine Viruses.

Based on Technology, market is studied across Culture-Independent Techniques and Isolation & Cultivation of Microorganisms.

Based on Application, market is studied across Aquaculture & Fishery, Biofuels, Drug Discovery, Environmental Health & Human Health, Food supply, and Industrial Products & Processes.

Based on End-User, market is studied across Chemical, Cosmetics, Energy, Food Industry, and Medical & Pharmaceutical.

Key Regional Insights Across Global Markets

Geographic analysis plays a pivotal role in understanding the global proliferation of marine biotechnology innovations. The Americas serve as a major hub of research, development, and commercialization, underpinned by robust governmental support and a strong foundation in biotechnological research. The region boasts a dynamic network of academic and private sector collaborators, which fosters a fertile ground for pioneering research and breakthrough compounds.

In Europe, the Middle East and Africa cluster, a tapestry of diverse regulatory environments and innovative research centers, significantly contributes to shaping market dynamics. This geographical segment is characterized by both long-established biotechnological institutes and emerging players who emphasize sustainable practices and environmental conservation. The collective expertise from these regions fuels advances in technology, thereby ensuring that marine biotechnology continues to evolve amidst challenging and variable market conditions.

The Asia-Pacific region also stands out as a rapidly growing market, driven by expansive economic growth and increasing investments in biotechnology infrastructure. This region's cultural emphasis on technological innovation and integration with traditional practices elevates its market stature, positioning it as a key player in leveraging marine resources. With a combination of academic excellence and strong industrial output, Asia-Pacific is charting a course toward unprecedented levels of market penetration. The comparative regional insights help clarify how diverse markets are not only aligned in seeking sustainable solutions but are also continuously influencing the global landscape of marine biotechnology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Market Innovation

A close examination of the major industry players reveals a landscape that is both competitive and collaborative. Prominent companies that are driving innovation in marine biotechnology include Aker BioMarine ASA, BASF SE, and Benchmark Holdings plc. These entities, along with others such as Biolchim Group by J.M. Huber Corporation and BioLume, Inc., are at the forefront of translating research into commercially viable solutions. Other innovators like BlueBioTech GmbH, Cellana Inc., and Corbion N.V. bolster the competitive edge of the sector by continuously introducing technologies and practices that push conventional boundaries.

Further stirring the industry are firms such as DSM-Firmenich AG, Earthrise Nutritionals LLC, and GeoMarine Biotechnologies (P) LTD, whose emphasis on integrated research and sustainable development has reinforced the role of marine biotechnology in modern industry. Companies like GlycoMar Ltd., Marine Biopolymers Ltd., and Marinova Pty Ltd. also contribute significantly with breakthrough innovations that redefine product reliability and performance. Marshall Marine Products, Nofima, and oceanBASIS GmbH add to this dynamic mix by steering innovation through collaborative research and strategic partnerships.

The landscape is also enriched by the contributions of Pharma Mar, S.A., PROLUME, LTD, Seppic S.A., and The GELITA Group, each of which has carved out unique niches across product and application segments. Veramaris V.O.F., Xanthella Ltd., and ZIVO Bioscience, Inc. further round out the profile of companies that are not only responding to current market demands but are also actively shaping the direction of future growth. The robust involvement of these companies demonstrates a comprehensive commitment to advancing sustainable and high-impact marine technologies.

The report delves into recent significant developments in the Marine Biotechnology Market, highlighting leading vendors and their innovative profiles. These include Aker BioMarine ASA, BASF SE, Benchmark Holdings plc, Biolchim Group by J.M. Huber Corporation, BioLume, Inc., BlueBioTech GmbH, Cellana Inc., Corbion N.V., DSM-Firmenich AG, Earthrise Nutritionals LLC, GeoMarine Biotechnologies (P) LTD, GlycoMar Ltd., Marine Biopolymers Ltd., Marinova Pty Ltd, Marshall Marine Products, Nofima, oceanBASIS GmbH, Pharma Mar, S.A., PROLUME, LTD, Seppic S.A., The GELITA Group, Veramaris V.O.F., Xanthella Ltd., and ZIVO Bioscience, Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are urged to pursue an agile yet strategic approach to meet the evolving challenges and opportunities in marine biotechnology. First, it is imperative to invest in state-of-the-art research infrastructure that leverages both culture-independent techniques and advanced isolation methodologies to fully utilize the genetic and biochemical diversity present in marine organisms. Concurrently, there should be an emphasis on developing integrated data analytics systems to generate actionable insights that blend market expectations with scientific breakthroughs.

Leaders must consider forging collaborative partnerships with academic institutions, research centers, and cross-sector specialists to accelerate product innovation and facilitate technology transfer. Engaging in public-private partnerships can further bolster the developmental ecosystem, ensuring that innovative solutions are not only financially viable but also meet stringent regulatory and sustainability benchmarks. Moreover, companies should align their strategies with the growing global emphasis on green technologies, promotion of environmental health, and sustainable manufacturing practices.

It is also recommended to embark on pilot projects that demonstrate the commercial viability of emerging marine technologies in specific sectors such as drug discovery, biofuels, and industrial processing. These initiatives serve as proof-of-concept and offer a blueprint for scaling up operations while mitigating risks. Furthermore, leaders should continuously upgrade their existing capabilities by adopting a robust risk management framework to navigate regulatory challenges and market volatilities. A strategic focus on customer-centric innovation will help align technological development with evolving consumer needs while securing competitive advantages in a dynamic global marketplace.

Conclusion: Navigating a Transformative Future

The dynamic realm of marine biotechnology is characterized by innovation, sustainability, and a compelling blend of traditional knowledge with modern science. This executive summary has provided a detailed overview of the transformative shifts influencing the industry, underscoring the importance of looking at diverse segmentation insights and regional dynamics. The analysis highlighted how subdivisions by product type, source, technology, application, and end-user collectively paint a picture of a versatile and rapidly evolving sector.

Moreover, regional insights reveal that each market, whether in the Americas, Europe, Middle East and Africa, or Asia-Pacific, brings its own unique strengths and challenges. This geographic diversity underlines the importance of tailored approaches that respect local market environments while harnessing global technological advancements. Furthermore, an in-depth review of key companies illustrates a competitive yet cooperative sector where leaders are not only challenging traditional paradigms but are setting new benchmarks for innovation and sustainability.

In conclusion, a holistic strategy that integrates advanced research, strategic collaborations, and a commitment to sustainable practices is vital for unlocking the full potential of marine biotechnology. While the journey ahead promises significant rewards, investment in talent, technology, and a resilient supply chain will be key for achieving enduring success in this transformative industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness about marine biodiversity and conservation
      • 5.1.1.2. Growing consumer demand for natural ingredients sourced from marine life
      • 5.1.1.3. Increasing pharmaceutical interest in marine-derived compounds
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing funding in marine genomics for the discovery of novel enzymes
      • 5.1.3.2. Rising demand for eco-friendly biofuels derived from marine algae
    • 5.1.4. Challenges
      • 5.1.4.1. Balancing sustainability and commercial interests in marine biotechnology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Proliferating preference for bioactive compounds owing to their antibacterial and anticancer properties
    • 5.2.2. Application: Rising significance of marine biotechnology in aquaculture and fishery sector
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Marine Biotechnology Market, by Product Type

  • 6.1. Introduction
  • 6.2. Bioactive Compounds
  • 6.3. Biomaterials

7. Marine Biotechnology Market, by Source

  • 7.1. Introduction
  • 7.2. Corals & Sponges
  • 7.3. Marine Algae
  • 7.4. Marine Fungi
  • 7.5. Marine Viruses

8. Marine Biotechnology Market, by Technology

  • 8.1. Introduction
  • 8.2. Culture-Independent Techniques
  • 8.3. Isolation & Cultivation of Microorganisms

9. Marine Biotechnology Market, by Application

  • 9.1. Introduction
  • 9.2. Aquaculture & Fishery
  • 9.3. Biofuels
  • 9.4. Drug Discovery
  • 9.5. Environmental Health & Human Health
  • 9.6. Food supply
  • 9.7. Industrial Products & Processes

10. Marine Biotechnology Market, by End-User

  • 10.1. Introduction
  • 10.2. Chemical
  • 10.3. Cosmetics
  • 10.4. Energy
  • 10.5. Food Industry
  • 10.6. Medical & Pharmaceutical

11. Americas Marine Biotechnology Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Marine Biotechnology Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Marine Biotechnology Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Dominican Republic launches first blue biotechnology company
    • 14.3.2. MiAlgae secured GBP 14 million to expand its operations for sustainable Omega-3s
    • 14.3.3. Regenics raised NOK 20.4 million to fund trials for Collex
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aker BioMarine ASA
  • 2. BASF SE
  • 3. Benchmark Holdings plc
  • 4. Biolchim Group by J.M. Huber Corporation
  • 5. BioLume, Inc.
  • 6. BlueBioTech GmbH
  • 7. Cellana Inc.
  • 8. Corbion N.V.
  • 9. DSM-Firmenich AG
  • 10. Earthrise Nutritionals LLC
  • 11. GeoMarine Biotechnologies (P) LTD
  • 12. GlycoMar Ltd.
  • 13. Marine Biopolymers Ltd.
  • 14. Marinova Pty Ltd
  • 15. Marshall Marine Products
  • 16. Nofima
  • 17. oceanBASIS GmbH
  • 18. Pharma Mar, S.A.
  • 19. PROLUME, LTD
  • 20. Seppic S.A.
  • 21. The GELITA Group
  • 22. Veramaris V.O.F.
  • 23. Xanthella Ltd.
  • 24. ZIVO Bioscience, Inc.

LIST OF FIGURES

  • FIGURE 1. MARINE BIOTECHNOLOGY MARKET MULTI-CURRENCY
  • FIGURE 2. MARINE BIOTECHNOLOGY MARKET MULTI-LANGUAGE
  • FIGURE 3. MARINE BIOTECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 4. MARINE BIOTECHNOLOGY MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. MARINE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. MARINE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MARINE BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MARINE BIOTECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOACTIVE COMPOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CORALS & SPONGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE ALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE FUNGI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MARINE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CULTURE-INDEPENDENT TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ISOLATION & CULTIVATION OF MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY AQUACULTURE & FISHERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL HEALTH & HUMAN HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY FOOD SUPPLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PRODUCTS & PROCESSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY ENERGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MARINE BIOTECHNOLOGY MARKET SIZE, BY MEDICAL & PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES MARINE BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM MARINE BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. MARINE BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 241. MARINE BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024